HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,528 | +0.4% | 40,000 | -5.2% | 0.01% | +16.7% |
| Q2 2023 | $1,522 | -56.0% | 42,200 | -53.4% | 0.01% | +20.0% |
| Q1 2023 | $3,459 | +129.5% | 90,600 | +241.9% | 0.01% | -28.6% |
| Q4 2022 | $1,507 | -99.9% | 26,500 | -39.8% | 0.01% | -12.5% |
| Q3 2022 | $1,739,000 | +48.6% | 44,000 | +65.4% | 0.01% | +60.0% |
| Q2 2022 | $1,170,000 | +30.4% | 26,600 | +18.2% | 0.01% | +66.7% |
| Q1 2022 | $897,000 | -56.6% | 22,500 | -56.2% | 0.00% | -57.1% |
| Q4 2021 | $2,066,000 | +3.9% | 51,400 | +5.1% | 0.01% | 0.0% |
| Q3 2021 | $1,989,000 | -10.4% | 48,900 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $2,220,000 | +206.2% | 48,900 | +181.0% | 0.01% | +166.7% |
| Q1 2021 | $725,000 | -6.7% | 17,400 | -4.4% | 0.00% | 0.0% |
| Q4 2020 | $777,000 | +79.4% | 18,200 | +10.3% | 0.00% | +50.0% |
| Q3 2020 | $433,000 | -5.5% | 16,500 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $458,000 | -3.8% | 17,100 | -35.5% | 0.00% | -33.3% |
| Q1 2020 | $476,000 | -59.2% | 26,500 | -59.8% | 0.00% | -40.0% |
| Q4 2019 | $1,168,000 | -46.3% | 65,900 | -53.0% | 0.01% | 0.0% |
| Q3 2019 | $2,174,000 | +80.6% | 140,200 | +100.0% | 0.01% | 0.0% |
| Q2 2019 | $1,204,000 | +12.2% | 70,100 | +5.1% | 0.01% | 0.0% |
| Q1 2019 | $1,073,000 | +10.1% | 66,700 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $975,000 | -18.1% | 66,700 | +1.7% | 0.01% | 0.0% |
| Q3 2018 | $1,191,000 | +7.7% | 65,600 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $1,106,000 | +1216.7% | 65,600 | +1425.6% | 0.01% | – |
| Q1 2018 | $84,000 | +10.5% | 4,300 | +13.2% | 0.00% | – |
| Q4 2017 | $76,000 | – | 3,800 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2015 | $105,000 | -41.0% | 6,100 | -54.1% | 0.00% | -100.0% |
| Q3 2015 | $178,000 | +36.9% | 13,300 | +129.3% | 0.00% | 0.0% |
| Q2 2015 | $130,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |